Stephen L. Lowe
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Alzheimer's disease and its progression reduce pyramidal cell gain and connectivity.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: January 09, 2025
Neurophysiological Progression in Alzheimer's Disease: Insights From Dynamic Causal Modelling of Longitudinal Magnetoencephalography.
Journal: Human brain mapping
Published: January 08, 2025
IQ Survey Results on Current Industry Practices-Part 1: Immunogenicity Risk Assessment.
Journal: Clinical pharmacology and therapeutics
Published: October 16, 2024
Discovery and clinical translation of ceperognastat, an O-GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's disease.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: July 15, 2024
Reliability of dynamic causal modelling of resting-state magnetoencephalography.
Journal: Human brain mapping
Published: October 17, 2023
Safety, Tolerability, and Pharmacokinetics of Zagotenemab in Participants with Symptomatic Alzheimer's Disease: A Phase I Clinical Trial.
Journal: Journal of Alzheimer's disease reports
Published: February 13, 2023
New Therapeutics in Alzheimer's Disease Longitudinal Cohort study (NTAD): study protocol.
Journal: BMJ open
Published: December 15, 2022
Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging.
Journal: The journal of prevention of Alzheimer's disease
Published: September 29, 2021
Robust Pharmacodynamic Effect of LY3202626, a Central Nervous System Penetrant, Low Dose BACE1 Inhibitor, in Humans and Nonclinical Species.
Journal: Journal of Alzheimer's disease reports
Published: August 06, 2021
Discovery and Early Clinical Development of LY3202626, a Low-Dose, CNS-Penetrant BACE Inhibitor.
Journal: Journal of medicinal chemistry
Published: June 03, 2021
Donanemab (LY3002813) dose-escalation study in Alzheimer's disease.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: October 14, 2020
Population Pharmacokinetic/ Pharmacodynamic Modelling of Auditory-Evoked Event-Related Potentials with Lorazepam.
Journal: Basic & clinical pharmacology & toxicology
Published: April 04, 2017
Last Updated: 09/26/2026